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Abstract
Background  and  objectives:  Children  with  Down  Syndrome  are  vulnerable  to  signiﬁcant  upper
airway obstruction  due  to  relative  macroglossia  and  dynamic  airway  collapse.  The  objective  of
this study  was  to  compare  the  upper  airway  dimensions  of  children  with  Down  Syndrome  and
obstructive sleep  apnea  with  normal  airway  under  dexmedetomidine  sedation.
Methods:  IRB  approval  was  obtained.  In  this  retrospective  study,  clinically  indicated  dynamic
sagittal midline  magnetic  resonance  images  of  the  upper  airway  were  obtained  under  low
(1 mcg/kg/h)  and  high  (3  mcg/kg/h)  dose  dexmedetomidine.  Airway  anteroposterior  diameters
and sectional  areas  were  measured  as  minimum  and  maximum  dimensions  by  two  indepen-
dent observers  at  soft  palate  (nasopharyngeal  airway)  and  at  base  of  the  tongue  (retroglossal
airway).
Results and  conclusions: Minimum  anteroposterior  diameter  and  minimum  sectional  area  at
nasopharynx  and  retroglossal  airway  were  signiﬁcantly  reduced  in  Down  Syndrome  compared  to
normal airway  at  both  low  and  high  dose  dexmedetomidine.  However,  there  were  no  signiﬁcant
differences  between  low  and  high  dose  dexmedetomidine  in  both  Down  Syndrome  and  normal
airway. The  mean  apnea  hypopnea  index  in  Down  Syndrome  was  16  ±  11.  Under  dexmedetomi-
dine sedation,  children  with  Down  Syndrome  and  obstructive  sleep  apnea  when  compared  to
normal airway  children  show  signiﬁcant  reductions  in  airway  dimensions  most  pronounced  at
the narrowest  points  in  the  nasopharyngeal  and  retroglossal  airways.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).∗ Corresponding author.
E-mail: Rajeev.Subramanyam@cchmc.org (R. Subramanyam).
ttp://dx.doi.org/10.1016/j.bjane.2014.11.019
104-0014/© 2015 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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PALAVRAS-CHAVE
Vias  aéreas;
Dexmedetomidina;
Imagem;
Síndrome  de  Down;
Apneia  obstrutiva  do
sono;
Sedac¸ão
Morfologia  das  vias  aéreas  superiores  em  pacientes  com  síndrome  de  Down  sob
sedac¸ão  com  dexmedetomidina
Resumo
Justiﬁcativa  e  objetivos:  As  crianc¸as  com  síndrome  de  Down  (SD)  são  vulneráveis  à  obstruc¸ão
signiﬁcativa  das  vias  aéreas  superiores  devido  à  macroglossia  relativa  e  colapso  dinâmico  das
vias aéreas.  O  objetivo  deste  estudo  foi  comparar  as  dimensões  das  vias  aéreas  superiores  de
crianc¸as com  SD  e  apnéia  obstrutiva  do  sono  (AOS)  com  vias  aéreas  normais  (VAN)  sob  sedac¸ão
com dexmedetomidina  (DEX).
Métodos:  Aprovac¸ão  IRB  foi  obtida.  Neste  estudo  retrospectivo,  imagens  clinicamente  indicadas
de ressonância  magnética  da  dinâmica  das  vias  aéreas  superiores  em  plano  sagital  na  linha
média foram  obtidas  sob  dose  baixa  (1  mcg/kg/h)  e  dose  alta  (3  mcg/kg/h)  de  DEX.  Os  diâmetros
ânteroposteriores  das  vias  aéreas  e  as  áreas  seccionais  foram  medidas  como  dimensões  mínimas
e máximas  por  dois  observadores  independentes,  no  palato  mole  (região  nasofaríngea)  e  na  base
da língua  (região  retroglossal).
Resultados  e  conclusões:  O  diâmetro  mínimo  anteroposterior  e  a  área  seccional  mínima  das
regiões nasofaríngea  e  retroglossal  estavam  signiﬁcativamente  reduzidos  na  SD  em  comparac¸ão
com VAN,  tanto  com  a  dose  baixa  quanto  com  a  dose  alta  de  DEX.  Contudo,  não  houve  diferenc¸as
signiﬁcativas  entre  as  doses  baixa  e  alta  de  DEX  em  SD  e  VAN.  A  média  do  índice  de  apneia
e hipopneia  na  SD  foi  de  16  ±  11.  Sob  sedac¸ão  com  DEX,  as  crianc¸as  com  SD  e  AOS  quando
comparadas  com  as  crianc¸as  com  VAN  apresentaram  reduc¸ões  signiﬁcativas  nas  dimensões  das
vias aéreas,  mais  pronunciadas  nos  pontos  mais  estreitos  das  regiões  nasofaríngea  e  retroglossal.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este
é um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Down  Syndrome  (DS)  or  trisomy  21  is  the  most  common
genetic  disorder  in  humans  with  an  estimated  birth  rate  of
6000  infants/year  (1  in  691  live  births)  in  the  United  States.1
Obstructive  sleep  apnea  (OSA)  is  common  and  noted  in  79%
of  children  with  DS  (95%  conﬁdence  interval,  54--94%).2 Risk
factors  for  OSA  in  these  children  include  midface  hypoplasia,
macroglossia,  adenoid  and  tonsillar  hypertrophy,  laryngotra-
cheal  anomalies,  obesity,  and  muscular  hypotonia.3 Even  in
the  absence  of  OSA,  children  with  DS  have  reduced  airway
size  caused  by  soft  tissue  crowding  within  a  smaller  facial
skeletal  anatomy.4
Children  with  OSA,  with  or  without  DS,  are  sensitive
to  respiratory  depression  by  opioids,  sedatives,  and  hyp-
notics.  They  are  especially  vulnerable  to  the  development  of
upper  airway  obstruction  during  sedation  and  anesthesia.5
Dexmedetomidine  (DEX)  is  an  -2  receptor  agonist  currently
being  used  off-label  for  sedation  in  pediatric  patients  at
many  institutions.  In  contrast  to  other  sedative  agents,  DEX
has  been  shown  to  have  sedative  properties  that  parallel
natural  non-rapid  eye  movement  sleep,  without  signiﬁcant
respiratory  depression.6,7 These  advantages  make  DEX  an
attractive  agent  for  sedating  children  with  OSA.8 We  have
previously  used  magnetic  resonance  imaging  (MRI)  to  assess
the  effect  of  increasing  doses  of  DEX  on  airway  dimensions  in
children  with  normal  upper  airways  (age  range  3--10  years)
and  showed  that  increasing  doses  of  DEX  in  these  children  is
not  associated  with  signiﬁcant  increase  in  the  degree  of  air-
way  obstruction.9 We  recently  used  a  similar  methodology
to  compare  the  dose--response  effects  of  DEX  and  propo-
fol  on  airway  morphology  in  children  with  OSA  (age  range
p
a
c--16  years).  We  found  that  as  the  dosage  increased,  aver-
ge  airway  dimensions  were  typically  unchanged  or  slightly
ncreased  with  DEX  compared  to  unchanged  or  slightly
ecreased  with  propofol.10
Our  aim  in  the  present  study  was  to  test  the  hypothe-
is  that  DS  children  with  OSA  have  signiﬁcant  upper  airway
ollapsibility  even  at  low  doses  of  DEX  compared  to  children
ith  normal  airway  (NA).  We  therefore  designed  a  retrospec-
ive  cohort  study  comparing  the  upper  airway  morphologies
f  children  aged  3--10  years  with  DS  and  OSA  to  those  with
A  under  increasing  doses  of  DEX  sedation.
aterials and methods
fter  institutional  review  board  approval,  the  data  were
btained  in  children  aged  3--10  years  with  DS  and  children
ith  NA  who  underwent  MRI  airway  analysis  with  DEX.  Writ-
en  informed  consent  had  been  obtained  for  sedation.  The
eed  for  a  separate  informed  consent  for  the  retrospective
eview  was  waived  by  our  IRB.
own  Syndrome  (DS)  group
he  methodology  used  in  children  with  DS  is  described  in
ur  previous  study  that  examined  the  dose--response  effects
f  DEX  and  propofol  on  airway  morphology.  This  was  done
n  22  children  and  adolescents  aged  3--16  years  with  a  his-
10atients  who  completed  the  study,  a subgroup  of  7  patients,
ged  3--10  years,  had  the  diagnosis  of  DS.  No  premedi-
ation  was  given.  Intravenous  access  was  obtained  in  the
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nduction  room  with  sevoﬂurane  and/or  nitrous  oxide
n  oxygen.  Atropine  10  mcg/kg  IV  was  administered  and
evoﬂurane  and/or  nitrous  oxide  were  discontinued.  DEX
as  started  and  MR  imaging  performed  as  described  below.
ormal  airway  (NA)  group
he  methodology  used  for  evaluation  of  children  with  nor-
al  airways  was  describe  in  a  previously  study.9 In  brief,
hildren  aged  3--10  years  who  presented  for  an  elective  MRI
xamination  under  sedation  were  included.  Children  with
istory  of  OSA  or  snoring,  American  Society  of  Anesthesiol-
gy  classiﬁcation  >2,  allergy  to  DEX,  presence  of  airway  or
raniofacial  abnormality,  obesity,  or  severe  developmental
elay  were  excluded.
exmedetomidine  protocol
aseline  airway  images  were  obtained  during  the  Low  DEX
nfusion  (1  mcg/kg/h).  If  the  subject  moved,  a  bolus  of
.5  mcg/kg  over  10  min  was  given  and  the  DEX  infusion  rate
as  increased  to  1.5  mcg/kg/h.  If  the  subject  moved  a  sec-
nd  time,  the  research  study  was  terminated  and  additional
nesthesia  was  provided  with  propofol  infusion.  After  the
nitial  set  of  airway  images  were  obtained,  a  bolus  dose  of
EX  2  mcg/kg  was  given  over  10  min  followed  by  an  increase
n  the  infusion  rate  to  3  mcg/kg/h  (high  dose  DEX).  Univer-
ity  of  Michigan  Sedation  Scale  (UMSS)  was  used  to  assess
edation.11 UMSS  is  a  simple  to  use,  validated  tool  to  assess
he  depth  of  sedation  in  children.11 Standard  monitoring  and
pontaneous  breathing  with  2  L/min  of  oxygen  via  nasal  can-
ula  was  used.  Level  of  sedation  was  assessed  after  initial
m
c
l
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igure  1  Still  image  (A)  from  a  sagittal  cine  clip  shows  the  nasop
rrows) as  open  and  the  still  image  (B)  shows  the  retroglossal  airwaR.  Subramanyam  et  al.
ow  dose  of  DEX  before  and  after  imaging.  Sedation  was
ot  assessed  during  imaging  as  this  may  have  necessi-
ated  changing  the  patient’s  head  position  and  subsequently
iasing  airway  measurement  comparisons.  Patients  were
ransferred  to  the  post  anesthesia  care  unit  following  imag-
ng  and  discharged  home  after  meeting  criteria.
R  imaging  protocol
ll  patients  underwent  clinically  indicated  MRI  under  DEX
edation.  Once  adequate  sedation  was  achieved,  the  cervi-
al  spine  was  maintained  in  a  neutral  position  by  placing  the
atient’s  head  and  neck  in  a  vascular  coil.  No  artiﬁcial  air-
ay  (e.g.,  oral  airway  or  nasal  trumpet)  or  positioning  aid
e.g.,  shoulder  roll)  was  used  during  imaging.  No  attempt
as  made  to  open  or  close  the  mouth.  Children  with  DS  were
ransferred  to  the  imager  after  the  sevoﬂurane  end-tidal
oncentration  was  reduced  to  <0.1%.  MRI  was  performed  on
 1.5  Tesla  imager  (GE  Healthcare,  Milwaukee,  WI,  USA)  with
n  8-channel  receiver  only  neurovascular  phased  array  coil
MEDRAD,  Inc.,  Indianola,  PA,  USA).  The  primary  images  for
nalysis  were  rapidly  acquired  in  a midline,  sagittal  plane
sing  fast  gradient  echo  imaging  (1  image  every  800  ms).9
he  scan  parameters  were:  Repetition  time/Echo  time:
.98/3.6,  Field  of  view:  24  cm,  slice  thickness:  5  mm,  matrix
56  ×  128,  number  of  excitations:  1,  ﬂip  angle:  80◦,  receiver
andwidth  244.1  Hz/pixel,  baseline  resolution:  256,  phase
esolution:  128.  By  playing  a cine  loop  of  the  images,  a
ovie  of  airway  motion  was  created  (Figs.  1  and  2  with  asso-
iated  video).  Upper  airway  images  were  obtained  during
ow  (1  mcg/kg/h)  and  high  (3  mcg/kg/h)  dose  DEX  sedation.
he  images  were  stored  on  the  PACS  (Picture  Archiving  and
harynx  airway  (short  arrows)  and  the  retroglossal  airway  (long
y  as  collapsed.
Down  Syndrome  airway  and  dexmedetomidine  391
ossal
patib
m
s
w
t
S
S
s
b
a
a
b
p
w
p
a
R
w
‘
a
A
R
W
a
aFigure  2  Still  image  (A)  from  the  cine  clip  shows  the  retrogl
image (B)  shows  the  airway  completely  collapsed  centrally  com
Communication  System)  and  reviewed  by  two  scorers  who
were  blinded  to  the  DEX  doses.
The  airway  was  measured  at  the  level  of  the  soft  palate
(nasopharyngeal  airway)  and  the  base  of  the  tongue  (ret-
roglossal  airway)  (Figs.  1  and  2).  The  sectional  area  and
anterior-posterior  diameter  were  measured  in  the  nasopha-
ryngeal  area  (NPA)  and  the  retroglossal  area  (RGA).  The
nasopharyngeal  area  (NPA)  was  deﬁned  anteriorly  by  a  verti-
cal  line  tangential  to  the  posterior  inferior  nasal  turbinate,
posteriorly  by  the  posterior  wall  of  nasopharynx,  superi-
orly  by  the  superior  wall  of  nasopharynx,  and  inferiorly  by
superior  and  posterior  part  of  hard  and  soft  palate.  The  ret-
roglossal  airway  area  (RGA)  was  deﬁned  anteriorly  by  the
back  of  tongue,  posteriorly  by  the  posterior  pharyngeal  wall,
superiorly  by  a  horizontal  line  drawn  at  the  inferior  margin
of  the  soft  palate,  and  inferiorly  by  a  horizontal  line  drawn
at  the  base  of  the  tongue.  The  sectional  area  and  antero-
posterior  diameter  were  measured  in  the  NPA  and  RGA  on
images  of  minimum  and  maximum  expansion  of  the  airway.
Power  analysis
Analyses  performed  with  R  statistical  software  indicated
that  a  sample  size  of  7  patients  would  have  an  80%  power  to
detect  a  100  mm2 difference  in  the  mean  sectional  areas  of
NA  and  DS  airways  in  children  under  low  dose  DEX.12 A  differ-
ence  of  100  mm2 was  chosen  because  children  with  DS  have
baseline  narrow  airways  and  was  based  on  a  95%  conﬁdence
level  in  the  mean  differences.13 Low  dose  DEX  was  chosen  in
order  to  determine  the  most  conservative  estimate  of  sam-
ple  size  necessary  to  adequately  power  the  study.  This  was
done  under  the  assumption  that  high  dose  DEX  would  cause
t
d
s
s airway  in  cross-section  while  open  (arrowheads)  and  the  still
le  with  hypopharyngeal  collapse.
ore  signiﬁcant  airway  narrowing  than  low  dose  DEX  and,
ubsequently,  the  mean  difference  in  airway  measurements
ould  be  larger.  A  post  hoc  power  analysis  was  performed
o  verify  this  assumption.
tatistical  analysis
tatistical  analysis  was  performed  with  R  statistical
oftware.12 Normality  of  distribution  of  data  was  checked
y  Shapiro--Wilks  test.  Descriptive  statistics  are  provided
s  mean  and  standard  deviation  or  numbers  as  appropri-
te.  Age,  weight,  and  polysomnography  derived  variables
etween  children  with  NA  and  children  with  DS  were  com-
ared  with  Welch  two-sample  t-test.  Gender  was  compared
ith  the  Fischer  exact  test.  Hemodynamic  data  were  com-
ared  with  the  unpaired  t-test.  The  minimum  and  maximum
nteroposterior  diameter  and  sectional  areas  in  the  NPA  and
GA  were  compared  between  children  with  DS  and  children
ith  NA  using  the  unpaired  t-test.  The  difference  between
low  dose  DEX’  and  ‘high  dose  DEX’  between  children  with  DS
nd  children  with  NA  was  compared  using  the  paired  t-test.
 p-value  of  <0.05  was  considered  statistically  signiﬁcant.
esults
e  studied  7  children  with  DS  and  23  children  with  NA.  The
ge,  weight,  and  polysomnography  ﬁndings  for  the  groups
re  presented  in  Table  1.  The  UMSS  sedation  scale  showed
hat  children  with  DS  had  signiﬁcantly  higher  sedation  scores
uring  induction,  but  similar  scores  in  the  post  anesthe-
ia  care  unit  (Table  1).  Heart  rate  and  blood  pressure  were
tatistically  similar  between  both  the  groups  (Table  2).
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Table  1  Demographic  and  polysomnography  ﬁndings.
Down
Syndrome
(n  =  7)
Normal
airway
(n  =  23)
p
Age  (years)  5  ±  1  6  ±  2  0.27
Weight (kg)  26  ±  11  22  ±  5  0.42
Male/females  4/3  12/11  1
Sedation  score
Induction  3  ±  1  2  ±  1  0.003
Post  anesthesia
care  unit
3  ±  0 3  ±  0  0.36
Obstructive  sleep
apnea  (n)
7  0
Polysomnography  ﬁndings
Apnea  hypopnea
index
(events/hour)
17  ±  11
(5.2--37.6)
--
Minimal  oxygen
saturation  (%)
81  ±  5
(72--85)
--
All data in mean ± standard deviation or absolute numbers.
Ranges are mentioned in parenthesis. --, not applicable.
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Table  2  Hemodynamic  data.
Baseline  p  First  
Down
Syndrome
Normal
children
Down
Syndrome
HR  (bpm)  101  ±  12  93  ±  14  0.15  97  ±  19  
SBP (mm  Hg)  110  ±  10  107  ±  14  0.50  125  ±  14  
DBP (mm  Hg)  64  ±  9  56  ±  19  0.16  69  ±  9  
HR, heart rate; SBP, non-invasive systolic blood pressure; DBP, non-inva
Table  3  Comparison  of  airway  dimensions  between  children  with
low and  high  dose  dexmedetomidine.
Dimensions  Low  dose  dexmedetomidine  
Down  Normal  95%  CI  p-V
Nasopharyngeal
AP  (mm)
Minimum  1  ±  1  5  ±  2  2.6--4.9  <0.
Maximum 2  ±  1  5  ±  2  2.6--5.1  <0.
Sectional area  (mm2)
Minimum  157  ±  41  265  ±  80  59.5--154.7  <0.
Maximum 198  ±  28  279  ±  82  39.8--122.1  <0.
Retroglossal
AP (mm)
Minimum  2  ±  2  10  ±  4  5.7--9.9  <0.
Maximum 7  ±  4 10  ±  4  −0.0  to  7.5  0.
Sectional area  (mm2)
Minimum  108  ±  63  245  ±  79  74.3--199.7  <0.
Maximum 227  ±  129  266  ±  89  −81.8  to  160.1  0.
AP, Antero-posterior; 95% CI, 95% conﬁdence interval for the mean diffR.  Subramanyam  et  al.
Airway  anteroposterior  diameter  and  sectional  area  mea-
urements  are  summarized  in  Table  3.
The  following  three  dimensions  were  reduced  signiﬁ-
antly  in  children  with  DS  as  compared  to  NA  at  both  low
nd  high  dose  DEX:  minimum  RGA  sectional  area,  minimum
nteroposterior  NPA  diameter,  and  minimum  anteroposterior
GA  diameter.  Sedation  with  DEX  did  not  yield  a  statistically
igniﬁcant  dose-dependent  (low  vs.  high)  difference  in  the
irway  measurements  of  children  with  DS  and  NA  (Table  4).
iscussion
ur  study  showed  that  children  with  DS  and  OSA  exhibited
igniﬁcant  reductions  in  anatomical  airway  dimensions  when
ompared  to  children  with  NA  under  DEX  sedation.  The  safe
edation  of  children  especially  those  with  a  history  of  OSA
equires  a clear  understanding  of  the  pharmacokinetic  and
harmacodynamic  effects  of  the  sedative  used  as  well  as  an
ppreciation  of  the  effect  of  the  chosen  sedative  on  airway
ollapsibility.  All  practitioners  providing  sedation  must  have
n  in  depth  understanding  of  the  interaction  between  depth
f  sedation  and  airway  dynamics,  remembering  that  depth
f  sedation  is  a  continuum  from  minimal,  moderate,  and
eep  sedation  to  general  anesthesia.
scan  p  High  dose  DEX  p
Normal
children
Down
Syndrome
Normal
children
78  ±  15  0.03  84  ±  9  82  ±  19  0.88
111  ±  15  0.13  137  ±  14  112  ±  14  0.08
59  ±  12  0.15  84  ±  2  66  ±  12  <0.001
sive diastolic blood pressure.
 Down  Syndrome  and  children  with  normal  airway  under  both
High  dose  dexmedetomidine
alue  Down  Normal  95%  CI  p-Value
001  1  ±  1  5  ±  2  2.3--4.7  <0.001
001  2  ±  1  5  ±  2  2.0--4.7  <0.001
001  171  ±  69  262  ±  75  7.2--175.0  0.04
001  199  ±  78  281  ±  71  −12.2  to  175.8  0.08
001  4  ±  3  9  ±  4  1.5--9.2  0.01
05  8  ±  4  10  ±  5  −2.2  to  6.7  0.27
001  121  ±  48  247  ±  104  60.1--191.5  0.001
48  210  ±  78  268  ±  108  −37.8  to  153.9  0.2
erences.
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Table  4  Comparison  of  mean  differences  in  airway  dimensions  between  low  and  high  dose  dexmedetomidine  in  children  with
normal airway  and  children  with  Down  Syndrome.
Dimensions  Down  (low  vs.  high  dose  DEX)  Normal  (low  vs.  high  dose  DEX)
Mean  difference  95%  CI  p-Value  Mean  difference  95%  CI  p-Value
Nasopharyngeal
AP  (mm)
Minimum  −0.4 −2.0  to  1.3  0.56  0.1  −0.4  to  0.5  0.79
Maximum −0.2 −1.9  to  1.5 0.76  0.3  −0.1  to  0.7  0.31
Sectional area  (mm2)
Minimum  −1.5 −120.5  to  117.5 0.97 2.2 −8.7  to  13.2 0.67
Maximum 6.3  −114.9  to  127.6  0.89  −2.4  −13.7  to  8.9  0.67
Retroglossal
AP (mm)
Minimum  −1.5  −5.4  to  2.3  0.33  0.7  −0.0  to  1.5  0.06
Maximum −2.0 −9.4  to  5.5  0.51  0.3  −0.5  to  1.2  0.41
Sectional area  (mm2)
Minimum  3.1  −109.4  to  115.7  0.94  −1.9  −17.8  to  14.0  0.81
Maximum 4.9  −168.0  to  177.8  0.94  −1.9  −19.8  to  16.0  0.83
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corresponding means from Table 3.
Sedating  or  anesthetizing  a  child  known  to  have  OSA  is
a  challenge  because  anesthetic  agents  blunt  arousal  mech-
anisms,  decrease  respiratory  drive,  and  reduce  pharyngeal
muscle  tone.  More  than  half  of  all  children  with  DS  have
OSA,  and  these  children  are  at  higher  risk  of  adverse  air-
way  events  during  procedural  sedation.  Our  study  examined
the  anatomical  sagittal  sectional  areas  and  diameter  at  the
critical  part  of  the  airway.  We  show  that  airway  sectional
areas  and  diameters  were  signiﬁcantly  reduced  in  children
with  DS  compared  to  those  children  with  NA  at  both  low
and  high  dose  DEX.  The  changes  in  airway  dimensions  were
not  dose-dependent  within  the  patient  groups.  The  seem-
ing  independence  of  airway  dimensions  and  DEX  dose  can
be  explained  by  the  relationship  between  consciousness  and
upper  airway  collapsibility.  Profound  changes  in  upper  air-
way  muscle  activity  and  collapsibility  occur  proximate  to  the
loss  of  consciousness  and  relatively  modest  changes  occur
with  increasing  depth  of  anesthesia/sedation.14
Furthermore,  we  quantitate  the  effect  of  DEX  sedation  on
airway  morphology  in  children  with  DS.  It  is  our  hope  that
practitioners  can  utilize  this  information  to  better  assess
the  depth  of  sedation  of  their  DS  patients  and  ultimately
avoid  the  adverse  effects  of  over  sedation  (e.g.  hypoven-
tilation,  airway  obstruction).  As  pediatric  DS  patients  can
rapidly  obstruct  their  airways  even  at  low  doses  of  seda-
tion,  providers  should  also  conﬁrm  that  airway  management
instruments  are  readily  available  before  sedating  these  chil-
dren.
Patients  with  DS  also  have  a  higher  chance  of  persistent
OSA  following  tonsillectomy  due  to  recurrent  enlargement
of  lingual  tonsils  and  adenoid  tissue,  reduced  muscular
tone,  hypopharyngeal  collapse,  and  glossoptosis.15,16 MRI  of
the  airway  in  adolescents  for  evaluation  of  OSA  revealed
that  children  with  DS  have  disproportionately  large  tongues
in  comparison  to  the  craniofacial  parameters  of  age-  and
gender-matched  controls.3 The  ﬁndings  from  the  present
c
i
D
rm the dataset and do not represent simply the difference of two
tudy  show  that  airway  size  was  stable  between  the  dosage
evels  of  DEX  studied.  This  suggests  that  the  airway  col-
apsibility  is  probably  caused  by  reduced  muscular  tone  and
ypopharyngeal  collapse,  glossoptosis,  midface  hypoplasia,
nd  relative  macroglossia.3,15,16 Pharyngeal  collapse  is  more
evere  in  children  with  DS  compared  to  controls,  indepen-
ent  of  age,  gender,  and  body  mass  index.17 The  augmented
pper  airway  dilator  activity  present  in  the  awake  state  is
educed  at  sleep  onset,  and  is  further  attenuated  during
apid  eye  movement  sleep,  contributing  to  pharyngeal  col-
apse  in  children  with  OSA.18,19 Additional  contributors  to
irway  obstruction  during  sedation  with  intravenous  pento-
arbital  in  children  with  moderate  OSA  include  large  soft
alate,  and,  large  adenoids  and  tonsils.20
The  airway  sectional  area  and  anteroposterior  diameter
ere  measured  as  minimum  and  maximum,  which  represent
imensions  during  inhalation  and  exhalation  respectively.
his  was  done  to  interpret  relative  changes  in  the  airway
uring  the  respiratory  cycle.  The  peak  image  acquisition  rate
f  800  ms  was  performed  and  allowed  for  random  sampling
uring  the  respiratory  cycle.  Segmentation  of  the  airway
ize  over  the  breathing  cycle  and  the  use  of  the  peak  size
nd  minimal  size  obviated  the  need  for  synchronization  to
he  respiratory  cycle.  The  airway  is  largest  during  expiration
nd  smallest  during  inspiration  unless  tongue/jaw  thrusting
s  present  and  the  airway  is  more  dynamic  in  OSA.21
The  baseline  caliber  of  the  airway  is  an  important  factor
n  the  dynamics  of  the  airway  movement  and  is  related  to
he  ﬂow  structure  interaction  between  the  ﬂowing  air  and
he  surrounding  soft  tissues.22 Thus,  the  narrowest  portions
f  the  airway  are  most  important  in  inducing  airway  col-
apse  than  the  larger  caliber  segments  of  the  airway.  The
hange  from  maximum  to  minimum  size  during  a  respiration
s  physiological  breathing-related  and  the  greater  degree  in
S  is  linked  to  both  the  OSA  and  the  smaller  size.  The  end
esult  is  a  signiﬁcantly  lower  functional  performance  and
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294  
igher  fatigability  seen  in  inspiratory  muscles  in  patients
ith  OSA.23
There  are  a  few  limitations  with  our  study.  Although  our
ample  size  remains  a  limitation  and  may  limit  our  sta-
istical  signiﬁcance  particularly  with  high  dose  DEX  group
asopharyngeal  area  measurements  (post  hoc  power  71%),
ur  preliminary  ﬁndings  are  relevant  in  deﬁning  and  apply-
ng  interventions  to  improve  airway  outcomes  in  children
ndergoing  sedation  outside  the  operating  room.  Second,
ll  of  the  patients  with  DS  in  our  study  had  moderate  to
evere  OSA.  The  ﬁndings  may  be  different  in  the  minority
f  those  patients  with  DS  with  no  OSA.  While  it  would  be
deal  to  study  DS  patients  with  no  OSA  as  a  third  group,  the
vailability  of  an  adequate  number  of  DS  patients  having  MRI
f  airway  for  non-OSA  indications  is  a  major  limiting  factor.
ast,  the  mean  sedation  score  in  children  with  DS  was  sig-
iﬁcantly  higher  during  induction  as  compared  to  children
ith  NA  and  may  have  affected  measurements  during  low
ose  DEX.  Although  UMSS  captures  changes  in  the  depth  of
edation,  the  inability  of  the  scale  to  discriminate  moderate
nd  deep  levels  of  sedation  may  limit  its  usefulness  in  such
ituations.24
onclusions
n  summary,  children  with  DS  with  OSA  exhibited  signiﬁcant
eductions  in  anatomical  airway  dimensions  when  compared
o  children  with  NA  under  DEX  sedation,  supporting  our
ypothesis.  The  relative  reduction  in  airway  dimensions  is
qual  at  both  low  dose  and  high  dose  DEX,  which  suggests
hat  the  observed  differences  are  unique  to  DS  and  not  due
o  differences  in  sedation.  These  changes  are  most  signif-
cant  at  the  narrowest  points  in  the  nasopharyngeal  and
etroglossal  airways.
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